DMRA
Damora Therapeutics, Inc.
NASDAQ: DMRA · HEALTHCARE · BIOTECHNOLOGY
$25.36
-1.17% today
Updated 2026-05-01
Market cap
$1.46B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.98
Dividend yield
—
52W range
$2 – $38
Volume
0.3M
Damora Therapeutics, Inc. (DMRA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |